CLN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Celon Pharma SA

Watchlist Manager

Watchlist

Price: 18.78 PLN -1.16% Market Closed

Market Cap: zł1B

C	Celon Pharma SA WSE:CLN	PL
M	Metals X Ltd F:FG5	AU
	SBM Offshore NV AEX:SBMO	NL
U	US Bancorp F:UB5	US

Profitability Summary

Celon Pharma SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

77%

Strong 3Y Average Gross Margin

73%

Gross Margin is Increasing

68% > 77%

Negative Operating Margin

-6%

Negative 3Y Average Operating Margin

-13%

Operating Margin is Increasing

-12% > -6%

Exceptional Net Margin

43%

Negative 3Y Average Net Margin

-9%

Net Margin is Increasing

-12% > 43%

Negative Free Cash Flow Margin

-22%

Negative 3Y Average Free Cash Flow Margin

-15%

Declining Free Cash Flow Margin

-14% > -22%

Exceptional ROE

25%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-8%

ROIC is Increasing

-8% > -2%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.